These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3817933)

  • 1. Apo C-III levels in type IV hyperlipoproteinemia associated with non-insulin dependent diabetes.
    Shoukry MI
    Indian J Med Res; 1986 Sep; 84():297-300. PubMed ID: 3817933
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gender differences and diabetic status in the relationship of blood apolipoprotein C-III, free fatty acids and triglycerides in subjects at risk for glucose intolerance].
    Flórez H; Méndez AJ; Jones L; Goldberg RB
    Invest Clin; 1999 Mar; 40(1):51-66. PubMed ID: 10198561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
    Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR
    Artery; 1985; 12(6):363-81. PubMed ID: 4051756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism with carotid intima-media thickness in Chinese type 2 diabetic patients.
    Chen X; Tian H; Liu R
    Diabetes Res Clin Pract; 2004 Oct; 66(1):41-7. PubMed ID: 15364160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of human plasma apolipoproteins C-I, C-II, and C-III by radioimmunoassays.
    Bren ND; Rastogi A; Kottke BA
    Mayo Clin Proc; 1993 Jul; 68(7):657-64. PubMed ID: 8350639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes.
    Gervaise N; Garrigue MA; Lasfargues G; Lecomte P
    Diabetologia; 2000 Jun; 43(6):703-8. PubMed ID: 10907114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct determination of apolipoprotein C-III specific activity using immunoaffinity chromatography.
    Le NA; Bukberg PR; Ginsberg HN; Gibson JC; Brown WV
    Methods Enzymol; 1986; 129():457-69. PubMed ID: 3523155
    [No Abstract]   [Full Text] [Related]  

  • 9. Bezafibrate lowers VLDL concentrations without modifying its structure.
    Kazumi T; Yoshino G; Matsuba K; Iwai M; Iwatani I; Kasama T; Yoshida M; Baba S
    Horm Metab Res; 1989 Jun; 21(6):341-2. PubMed ID: 2777193
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency.
    Marçais C; Bernard S; Merlin M; Ulhmann M; Mestre B; Rochet-Mingret L; Revol A; Berthezene F; Moulin P
    Diabetologia; 2000 Nov; 43(11):1346-52. PubMed ID: 11126401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia.
    Kashyap ML; Hynd BA; Robinson K; Gartside PS
    Metabolism; 1981 Feb; 30(2):111-8. PubMed ID: 7464559
    [No Abstract]   [Full Text] [Related]  

  • 12. The association between primary gout and hypertriglyceridaemia may be due to genetic linkage.
    Ferns GA; Lanham J; Galton DJ
    Monogr Atheroscler; 1985; 13():121-3. PubMed ID: 3937047
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hypertriglyceridaemia associated with altered apolipoprotein C and E composition of the triglyceride-rich lipoproteins.
    Stalenhoef AF; Demacker PN; Lutterman JA; Van't Laar A
    Neth J Med; 1981; 24(4):145-51. PubMed ID: 7279085
    [No Abstract]   [Full Text] [Related]  

  • 15. [From clinical tests to etiology: analysis of clinical features. Deficiency of apolipoproteins].
    Yamamura T; Yamamoto A
    Rinsho Byori; 1987 Dec; Spec No 75():93-108. PubMed ID: 3448286
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlations between the apoprotein C composition of very-low-density lipoproteins and triglyceridemia in subjects with type IV hyperlipoproteinemia.
    Lambert D; Max JP; Mejean L; Pointel JP; Drouin P; Debry G
    J Lab Clin Med; 1981 Jun; 97(6):834-41. PubMed ID: 7229513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between MspI polymorphism of the APO AI gene and Type 2 diabetes mellitus.
    Morcillo S; Cardona F; Rojo-Martínez G; Esteva I; Ruíz-de-Adana MS; Tinahones F; Gómez-Zumaquero JM; Soriguer F
    Diabet Med; 2005 Jun; 22(6):782-8. PubMed ID: 15910632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantification of very low density lipoprotein apo C and apo E peptides by isoelectric focusing in type IV hyperlipidemia, familial chylomicronemia and xanthelasma palpebrae without hyperlipidemia (author's transl)].
    Wada K; Miki H; Okuda F; Kusukawa R
    Nihon Ronen Igakkai Zasshi; 1981 Nov; 18(6):410-6. PubMed ID: 7339080
    [No Abstract]   [Full Text] [Related]  

  • 19. Apolipoprotein CII & CIII in non-insulin dependent diabetic patients.
    Kodikara M; Hobbs CG; Bordin P; Pacy PJ; Venkatasan S; Halliday D
    Biochem Soc Trans; 1996 May; 24(2):172S. PubMed ID: 8736830
    [No Abstract]   [Full Text] [Related]  

  • 20. Parallel increase of plasma apoproteins C-II and C-III in Type 2 diabetic patients.
    Béliard S; Nogueira JP; Maraninchi M; Lairon D; Nicolay A; Giral P; Portugal H; Vialettes B; Valéro R
    Diabet Med; 2009 Jul; 26(7):736-9. PubMed ID: 19573124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.